SANJIVANI PARANTERAL
Back to All Ratios
|
SANJIVANI PARANTERAL Last 5 Year EV/Core EBITDA History
[Consolidated]
| Mar2025 | Mar2024 | |
|---|---|---|
| EV/Core EBITDA(x) | 25.12 | 19.04 |
What is the latest EV/Core EBITDA ratio of SANJIVANI PARANTERAL ?
| Year | EV/Core EBITDA |
|---|---|
| Mar2025 | 25.12 |
| Mar2024 | 19.04 |
How is EV/Core EBITDA of SANJIVANI PARANTERAL Trending?
| Years | EV/Core EBITDA | % Change | |
|---|---|---|---|
| Mar2025 | 25.12 | 31.93 | |
| Mar2024 | 19.04 | - | |
Other Financial Ratios of SANJIVANI PARANTERAL
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/Core EBITDA ratio of peers of SANJIVANI PARANTERAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SANJIVANI PARANTERAL | ₹205.4 Cr | -2.8% | -13.2% | -29.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,679.0 Cr | -1.8% | -7% | 14.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,408.0 Cr | -3.4% | 0.4% | 58.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,634.0 Cr | -2.7% | -3.6% | 36% | Stock Analytics | |
| CIPLA | ₹109,063.0 Cr | -3.9% | -4.7% | -10.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,166.0 Cr | 3% | 6.1% | -3.8% | Stock Analytics | |
SANJIVANI PARANTERAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SANJIVANI PARANTERAL | -2.8% |
-13.2% |
-29.3% |
| SENSEX | -3.1% |
-6.2% |
-11.7% |
You may also like the below Video Courses